Literature DB >> 14586714

The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids.

Man-Chang Liu1, Shoichi Maruyama, Masashi Mizuno, Yoshiki Morita, Shigeru Hanaki, Yukio Yuzawa, Seiichi Matsuo.   

Abstract

BACKGROUND: Although Aristolochia manshuriensis (AM), which was incriminated in the Japanese variety of Chinese herbs nephropathy, has been recently shown to be nephrotoxic in rats, less is known about whether this toxicity is attributable to its aristolochic acids (AA). We compared the renal effect of AM with that of Akebia quinata (AQ), which has similar components to AM but is free of AA; we also compared this effect of AM with that of pure AA, and studied its possible mechanism.
METHODS: In study 1, rats were divided into four groups. Each group was orally given either 0.4 g of AM, 4 g of AM, or 4 g of AQ per day, or vehicle, for 5 days. In study 2, rats were given 4 g of AM (which contained 4 mg of AA), or 4 mg of pure AA per day, or vehicle, for 5 days. Renal function, and renal histology were evaluated on day 5 in study 1 and on days 1, 3, 5, and 14 in study 2. In study 2, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) and proliferating cell nuclear antigen (PCNA) staining were also performed. In study 3, rats were treated in the same way as in study 2, but were all killed on day 5. Concentrations of AA (I + II) were measured in serum and urine in study 2, and in the kidney, lung, heart, liver, and spleen in study 3.
RESULTS: In study 1, only the rats that received 4 g/day of AM developed tubular necrosis, azotemia, proteinuria, and glucosuria. In study 2, both AM- and AA-treated rats showed progressive tubular damage, decreased renal function, and increased urinary protein excretion. The degree of these alterations was comparable in the AM and AA groups. Moreover, the concentrations of AA (I + II), in serum, urine, and kidney were also comparable in the AM- and AA-treated rats. High levels of AA were detected in the lung and kidney. Apoptotic tubular cells increased on day 5 and had decreased by day 14 after the withdrawal of AM or AA. Meanwhile, proliferating tubular cells progressively increased from day 3 to day 14.
CONCLUSIONS: Our study indicates that the renal toxicity of AM can be attributed to its AA component. Tubular cell apoptosis might be one of the mechanisms involved in this renal injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586714     DOI: 10.1007/s10157-003-0229-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  11 in total

1.  Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemorif; Takeshi Sugaya; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

2.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

3.  Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats.

Authors:  L Patrice McDaniel; Elizabeth R Elander; Xiaoqing Guo; Tao Chen; Volker M Arlt; Nan Mei
Journal:  Environ Mol Mutagen       Date:  2012-04-17       Impact factor: 3.216

4.  Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats.

Authors:  Tao Chen; Lei Guo; Lu Zhang; Leming Shi; Hong Fang; Yongming Sun; James C Fuscoe; Nan Mei
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

5.  Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.

Authors:  Travis Bui-Klimke; Felicia Wu
Journal:  Risk Anal       Date:  2014-06-20       Impact factor: 4.000

Review 6.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

7.  Identification and determination of the major constituents in traditional Chinese medicine Longdan Xiegan Pill by HPLC-DAD-ESI-MS.

Authors:  Hui Liu; Juan Su; Xu Liang; Xi Zhang; Ya-Jun He; Hai-Qiang Huang; Ji Ye; Wei-Dong Zhang
Journal:  J Pharm Anal       Date:  2012-01-30

Review 8.  Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the rat.

Authors:  Masashi Mizuno; Yasuhiko Ito; B Paul Morgan
Journal:  Mar Drugs       Date:  2012-07-23       Impact factor: 6.085

9.  In Vitro and In Vivo Genotoxicity Assessment of Aristolochia manshuriensis Kom.

Authors:  Youn-Hwan Hwang; Taesoo Kim; Won-Kyung Cho; Hye Jin Yang; Dong Hoon Kwak; Hyunil Ha; Kwang Hoon Song; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-11       Impact factor: 2.629

10.  The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats.

Authors:  Pinpat Tripatara; Winita Onlamul; Suksalin Booranasubkajorn; Jantanee Wattanarangsan; Sukit Huabprasert; Natchagorn Lumlerdkij; Pravit Akarasereenont; Tawee Laohapand
Journal:  BMC Complement Altern Med       Date:  2012-10-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.